Form 4: Zura Bio Director Sandeep Chidambar Kulkarni Acquires Share Options

Director Sandeep Chidambar Kulkarni of Zura Bio Ltd. reports acquisition of share options.

Summary

• Sandeep Chidambar Kulkarni, a director of Zura Bio Ltd, filed a Form 4 with the SEC.
• The filing reports a transaction on May 21, 2025, where Kulkarni acquired 51,000 share options with an exercise price of $1.03.
• These options vest in twelve equal monthly installments over one year from the grant date, with any remaining unvested portion vesting before the next annual shareholder meeting, contingent on continued service.
• Following the transaction, Kulkarni directly owns 51,000 derivative securities (share options).

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard SEC filing reporting a director's acquisition of share options. It doesn't inherently indicate positive or negative news, but rather provides transparency.

Positives

• The acquisition of share options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure required by the SEC for insiders who trade in their company's securities. It provides transparency to the market regarding the holdings and transactions of company directors.

Stakeholder Impact

• Shareholders are informed about the director's stake in the company through the share options.

Key Dates

Keywords

Zura Bio, Director, Share Options, Form 4, SEC Filing, Kulkarni, Beneficial Ownership